F
Fuad S. Shihab
Researcher at University of Utah
Publications - 98
Citations - 3887
Fuad S. Shihab is an academic researcher from University of Utah. The author has contributed to research in topics: Kidney transplantation & Transplantation. The author has an hindex of 30, co-authored 96 publications receiving 3662 citations. Previous affiliations of Fuad S. Shihab include Mayo Clinic & Oregon Health & Science University.
Papers
More filters
Journal ArticleDOI
A Prospective, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial Comparing Early (7 Day) Corticosteroid Cessation Versus Long-Term, Low-Dose Corticosteroid Therapy
E. Steve Woodle,M. Roy First,John D. Pirsch,Fuad S. Shihab,A. Osama Gaber,Paul Van Veldhuisen +5 more
TL;DR: Early CSWD, compared with CCS, is associated with an increase in BCAR primarily because of mild, Banff 1A, steroid-sensitive rejection, yet provides similar long-term renal allograft survival and function.
Journal ArticleDOI
Results of the double-blind, randomized, multicenter, phase III clinical trial of thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation
Osama Gaber,M. Roy First,Raymond J. Tesi,Robert S. Gaston,Robert Mendez,Laura L. Mulloy,Jimmy A. Light,Lillian W. Gaber,E. C. Squiers,Rodney J. Taylor,John F. Neylan,Robert W. Steiner,Stuart J. Knechtle,Douglas J. Norman,Fuad S. Shihab,Giacomo Basadonna,Daniel C. Brennan,Ernest E. Hodge,Barry D. Kahan,Lawrence Kahana,Steven M. Steinberg,E. Steve Woodle,Laurence Chan,John M. Ham,Robert J. Stratta,Erik Wahlstrom,Kathleen R. Lamborn,H. Rossiter Horn,Hana Berger Moran,Philippe Pouletty,Timothy J. Schroeder +30 more
TL;DR: Thymoglobulin was found to be superior to Atgam in reversing acute rejection and preventing recurrent rejection after therapy in renal transplant recipients.
Journal ArticleDOI
Role of transforming growth factor-β1 in experimental chronic cyclosporine nephropathy
Fuad S. Shihab,Takeshi F. Andoh,Takeshi F. Andoh,Amie M. Tanner,Amie M. Tanner,Nancy A. Noble,Nancy A. Noble,Wayne A. Border,Wayne A. Border,Nora Franceschini,Nora Franceschini,William M. Bennett,William M. Bennett +12 more
TL;DR: A salt-depleted rat model of chronic CsA nephropathy shows similarity to the structural and functional lesions described in patients, and mRNA expression of plasminogen activator inhibitor, a protease inhibitor stimulated by TGF-beta 1, followed TGF
Journal ArticleDOI
Transforming growth factor-beta and matrix protein expression in acute and chronic rejection of human renal allografts.
Fuad S. Shihab,Tarsuo Yamamoto,Cynthia C. Nast,Arthur H. Cohen,Nancy A. Noble,Leslie I. Gold,Wayne A. Border +6 more
TL;DR: Results suggest that TGF-beta may play a role in the pathogenesis of fibrosis in chronic rejection, and acute rejection episodes are a good predictor for chronic rejection.
Journal ArticleDOI
Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation
Michael Charlton,William J. Wall,Akinlolu O. Ojo,Pere Ginès,Stephen C. Textor,Fuad S. Shihab,Paul Marotta,Marcelo Cantarovich,James D. Eason,Russell H. Wiesner,Michael A. E. Ramsay,Juan Carlos García-Valdecasas,James M. Neuberger,Sandy Feng,Connie L. Davis,Thomas A. Gonwa +15 more
TL;DR: This research presents a novel and scalable approach that combines traditional and innovative approaches to liver transplantation that addresses the challenges faced in selecting a single donor for a single organ.